Israel-Hamas war may singe billion-dollar pharma exports
The ongoing war between Israel and Palestine is threatening to disrupt the Indian pharmaceutical industry by hindering exports to several countries in the Middle East and North Africa (MENA) region.
Pharma industry experts estimate that if the war continues beyond two weeks, it is likely to dent the flow of pharma exports to the region, and countries nearby.
“India’s exports amount to a billion dollars per year in these countries,” one of the experts said, asking not to be named. He said a protracted Israeli-Palestinian war would impact flight services to these countries and subsequently hit pharma exports from India.